Discovery Matters

Discovery Matters

By Discovery MattersScienceLife Sciences
Download on the App Store

Discovery Matters episodes

  • 74. Patient-derived organoids (part 1)

    In this episode of Discovery Matters, we explore the incredible advances in precision medicine enabled by organoid technology. Vicky Marsh Durban and Oksana Sirenko contribute to the conversation, talking about how machine learning and robotics are used to scale up organoid culture and analyse data, as well as the potential of organoids to revolutionise regenerative medicine. Listen to this episode for an insightful and informative deep dive into the potential of organoids for transforming the face of modern medicine.


    Transcript

    Keywords: patient, cells, tissues, cardiac, drugs, assays, cancer, organoids, data, technology, stem cells, tumors, automation, ai.

    24 min
  • 73. War! What is it good for?

    War! What is it good for? In this episode of Discovery Matters, Dr Smith explains how military medicine first shaped state medicine and how wartime creates an opportunity to innovate. From advances in prosthetics, psychology, and cosmetic surgery to the mass production of penicillin during World War II, this episode dives deep into the life-saving innovations brought over the line due to conflicts.

    Show notes

    • More is Better: English Language Statistics are Biased Toward Addition - Winter - 2023 - Cognitive Science - Wiley Online Library
    • Protecting maternal health in Rwanda | MIT News | Massachusetts Institute of Technology
    • Transcript

      Keywords: medicine, war, military, wartime, innovation, doctors, civilian, patient, ai, medical, human, diseases, historian, psychiatry, navy, history.

      16 min
    • 72. Cryogenic cold chains and CAR T

      John Morris, a scientist at the forefront of cryopreservation technology, joins Dodi and Conor. They discuss the impact of cryopreservation on the development of CAR T therapies, why freezing cells is essential to these treatments, how tracking the samples ensures quality, and the potential for frozen cells to treat solid tumors in the future. Tune in to find out how cryopreservation has transformed the life sciences and how it could revolutionize how we treat disease in the future.

      Show notes

      Pioneers and Visionaries docu-series.

      Transcript

      Keywords: patient, cells, freezing, therapies, gene therapy, car t, t cells, john Morris, cytiva, podcast, stabilizing, cryogenics, cold chain

      15 min
    • 71. Revived therapies (part 2) - Phage therapy

      Conor and Dodi explore the new and exciting world of bacteriophage therapy. Join them as they speak to Anton Peleg, Professor of Infectious Diseases and Microbiology and the Director of the Department of Infectious Diseases at the Alfred Hospital and Monash University, about this emerging field. Together they discuss how phages, viruses that specifically target bacteria, are being used to fight against antibiotic-resistant superbugs and the challenges of producing them at scale and getting them approved by regulatory bodies.

      Show notes

      For more information on Professor Anton Peleg’s work with phages: Old cure revived in fight against antibiotic-resistant superbugs (smh.com.au)

      RNA in space: Oba, Y., Koga, T., Takano, Y. et al. Uracil in the carbonaceous asteroid (162173) Ryugu. Nature Communications 14, 1292 (2023). https://doi.org/10.1038/s41467-023-36904-3

      Transcript

      Keywords: phage, bacteria, infection, antibiotics, rna, therapies, bacterial infections, penicillin, patients, antibiotic resistant bacteria, cholera, phage therapy, superbugs.

      21 min
    • 70. Anti-cancer molecules

      In the latest episode of Discovery Matters, Dodi and Conor are joined by Dr. Bradley Moore from the Scripps Institution of Oceanography to discuss his research into the medical and synthetic implications of using marine microbes to fight aggressive cancers such as glioblastoma. By leveraging salinosporamide A, Dr. Moore proposes that these deep-sea organisms could potentially be scaled up for human use and repurposed for medicinal and synthetic purposes. Dive into this episode to hear how the ocean has the power to bring forth new discoveries that could save lives!

      Show notes

      For more information on this 'anti-cancer weapon': Scientists Discover How Molecule Becomes Anticancer Weapon | Scripps Institution of Oceanography (ucsd.edu)

      Transcript

      Keywords:

      glioblastoma, salinosporamide A, Scripps, chemicals, organisms, coral, ocean, genomes, dna, molecules, medicine, bacterium, drug, oceanography, sequence, sea.

      15 min
    • 69. Never underestimate a cell

      We should not underestimate cells. Conor and Dodi talk with Dr Brett Kagan, who conducted research to understand the brain and test ‘sentient’ brain cells, using the 1970s game, known as ‘Pong’. In another conversation, Professor Petra Levin and Kunaal Joshi explain how they have demonstrated that there is no mythical ‘average’ cell which mimics the stochastic behaviors of any individual cell.

      At the end of this episode, we hope to have proven that cells are not to be overlooked and still have so much to tell us about human health.

      Show notes

      • In vitro neurons learn and exhibit sentience when embodied in a simulated game-world
      • Beyond the average: An updated framework for understanding the relationship between cell growth, DNA replication, and division in a bacterial system
      • Transcript

        Keywords: cells, replication, pong, gamification, average, machine learning, brain cells, dna replication, intelligence, sleep, biology, biomass, bacteria, neurons.

        23 min
      • 68. CRISPR and molecular aging

        What do CRISPR and longevity have in common? Not much, except it's all molecular.

        We spoke to two different CEOs focused on improving human health. We begin with Dr Benjamin Oakes, Co-Founder, President, and CEO of Scribe Therapeutics, who takes us through the discovery, potential, and possible limitations of CRISPR.

        Then we are joined by fellow visionary Kristen Fortney, the CEO and co-founder of BioAge, a clinical-stage biotechnology company developing therapies that treat disease by targeting the biology of ageing.

        You cannot miss these fascinating conversations.

        Transcript

        Keywords: ageing, CRISPR, molecules, age, technology, disease, muscle, engineering, treat, understand, genome editing, human, Jennifer Doudna.

        26 min
      • 67. Revived therapies (part 1): Psychedelics

        Psychedelic treatment is a therapy which is on the rise according to the increasing number of studies on the use of psilocybin, ketamine and MDMA to treat mental health disorders such as PTSD. In this episode, Conor talks to Prof. Eric Vermetten, a psychiatrist who has been working with the military in the Netherlands for the last 25 years, helping Dutch armed forces and the uniformed people in the face of PTSD and psychotraumatology.

        Show notes

        For more info on Prof. Eric Vermetten’s work: Eric Vermetten - Leiden University (universiteitleiden.nl)

        Transcript

        Keywords: MDMA, psilocybin, psychedelics, PTSD, compounds, therapy, drugs, psychotraumatology, trauma, ketamine, revived therapies

        25 min
      • 66. Getting ÄKTA ready in virtual reality

        Conor and Dodi try their hand at learning to operate an ÄKTA ready in virtual reality. Their virtual journey takes them to Singapore and Miami, without leaving Sweden, Amersham, and Edinburgh. Join us on a journey into the metaverse.

        Show notes

        For more info on using virtual reality for customers: cytiva.com/vr

        You can view the video version of the episode here, where you can see virtual Dodi and Conor interact with virtual Arron Greig (our expert guide).

        Transcript

        Keywords: virtual reality, meetings, vr, learning, training, virtual, instructions, ÄKTA

        26 min
      • 65. Best of 2022

        Mushrooms on Mars, life-saving blood from worms, cell-cultured seafood. It's been a year filled with surprise, serendipity, and everything in between. Conor, Dodi and the podcast team look back on a fascinating year and highlight their favourite interviews and topics of the year. 

        See you in the new year!

        Show notes

        More info on Conor’s favorite: What is Quorn mycoprotein? | Quorn

        More info on Dodi’s favorite: How We Make Chocolate and Coffee From Plant Cell Culture Technology — The Future of Coffee and Chocolate | California Cultured (cacultured.com)

        More info on Beth’s favorite: Discovery Makers: Mustapha Bittaye | Cytiva (cytivalifesciences.com)

        More info on Tom’s favorite: Kevill JL, Pellett C, Farkas K, Brown MR, Bassano I, Denise H, McDonald JE, Malham SK, Porter J, Warren J, Evens NP, Paterson S, Singer AC, Jones DL. “A comparison of precipitation and filtration-based SARS-CoV-2 recovery methods and the influence of temperature, turbidity, and surfactant load in urban wastewater,” Sci Total Environ. 2022 Feb 20;808:151916. doi: https://doi.org/10.1016/j.scitotenv.2021.151916

        Transcript

        17 min

      About Discovery Matters

      From the publisher's feed

      A collection of stories and insights on matters of discovery that advance life sciences. Brought to you by the curious people at Cytiva.